Antiplasmodial Activity and Cytotoxicity of Semi Purified Fractions from Zanthoxylum zanthoxyloïdes Lam. Bark of Trunk
The aim of the study is to investigate through traditional medicinal plants the possibility for discovery and development of new active and safe antimalarial drugs. For ecological reasons, bark of trunk of Zanthoxylum zanthoxyloides instead to roots was used by traditional healers in Burkina Faso to treat malaria or fever and recent study showed that crude alkaloid extract from the bark of trunk displayed good antiplasmodial activity. The bio-guided chromatographic fractionation of this crude alkaloid extract with solvents yielded 11 semi purified fractions which were tested for their antiplasmodial activity and cytotoxicity, respectively against Plasmodium falciparum W2 strains and K562S cells maintained in continuous culture and using flow cytometer. Non polar fractions 2, 3 and 4 displayed good antiplasmodial activity with IC50 ranging from 1.91 to 4.32 μg mL-1 and little toxicity with selectivity index ranging from 3.03 to 6.15. These data allow further investigations in terms of purification, isolation and development of new antiplasmodial compounds from these semi purified fractions and development of improved phytomedicine.
to cite this article:
A. Gansane, S. Sanon, P.L. Ouattara, S. Hutter, E. Ollivier, N. Azas, A. Traore, A.S. Traore, I.P. Guissou, I. Nebie and B.S. Sirima, 2010. Antiplasmodial Activity and Cytotoxicity of Semi Purified Fractions from Zanthoxylum zanthoxyloïdes Lam. Bark of Trunk. International Journal of Pharmacology, 6: 921-925.
Received: July 29, 2010;
Accepted: September 09, 2010;
Published: October 04, 2010
Malaria is a major health problem in many developing countries and is responsible
for 300 to 500 million clinical cases worldwide (Rogier
and Trape, 1999) with around 1 million deaths each year, mainly in sub-Saharan
Africa (Snow et al., 1999; Rowe
et al., 2006). The rising resistance of Plasmodium falciparum
to affordable antimalarials such as chloroquine (Gansane
et al., 2009a, b) makes discovery and development
of new active and safe antimalarial drugs increasingly important. Therefore
research into new antimalarial drugs from natural products is worthy priority
in sub-Saharan Africa. Zanthoxylum zanthoxyloides Lam. (Rutaceae) previously
named Fagara zantoxyloides Lam. is very well known species, widely used
in the African pharmacopoiea, frequently mentioned and for which crude extracts,
semi purified and pure compounds from roots have already been evaluated in
vitro against Plasmodium strains (Kassim et al.,
2005). For ecological reason, the bark of trunk, is also used by the local
population of Comoe, western part of Burkina Faso for the treatment of fever
or malaria (Traore et al., 2009) and the antiplasmodial
activity of crude alkaloid extract of bark of trunk has been previously evaluated
and showed a good IC50 = 1.16 μg mL-1 against W2
Plasmodium falciparum strains (Gansane et al.,
2009a, b). The aim of this study was to realize
the bio-guided chromatographic fractionation of the crude alkaloid extract derived
from Zanthoxylum zanthoxyloides bark of trunk and to evaluate antiplasmodial
property and toxicity, respectively against W2 Plasmodium falciparum
resistant strains and K562S cell of semi purified alkaloids fractions obtained
by chromatography methods.
MATERIALS AND METHODS
Place and duration of study: The fractionation and in vitro testing with semi purified fractions were performed from March to October 2009, respectively in the Department of Pharmacology and Toxicology, University of Ouagadougou (Burkina Faso), Burkina Faso and in the laboratory of Parasitology in the Faculty of Pharmacy, University of the Mediterranea (France).
Semi purified alkaloids fractions: Z. zanthoxyloïdes (Lam.)
Zepen. and Timber was selected following socio-anthropological
and ethnobotanical surveys conducted in 2006 in the province of Comoe, located
in western Burkina Faso, 440 km from Ouagadougou, the capital city (Traore
et al., 2009). Crude total alkaloid extract was obtained from bark
of trunk of Zanthoxylum zanthoxyloides as described by Gansane in previous
step of this research (Gansane et al., 2009a).
The extract was dissolved in chloroform and fractionated using Preparative Thin
Layer Chromatography (TLC) 20x20 on G60 F254 silica gel Merck and cyclohexane/
toluene/diethylamin (75/15/10) was used as mobile phase. After solvent migration
plates were removed from the mobile phase and dried. The visualization of the
separated bands on PTLC was done using short (254 nm) and long (366 nm) wavelength
UV light to reveal semi-purified alkaloids fractions. Each fraction on silica
gel was removed with meticulous care, dissolved in chloroform, filtered on Whatman
paper A1 and weighted. TLC analysis was performed for each fraction and based
on the results of the thin layer chromatogram, identical fractions were pooled
and then submitted to biological evaluations after the evaporation of the solvent
under reduce pressure at 40°C giving dried residue of each fraction. Spraying
of Dragendorffs reagent on thin layer chromatogram plates were used to
reveal the presence of alkaloid in each fraction.
All semi purified alkaloids fractions were solubilized in 100% sterile DMSO (Dimethyl sulfoxide). All solutions were homogenous. The initial concentration of all solutions was 10 μg μL-1. Serial dilutions were made to obtain different concentrations of fractions (25, 12.5 and 6.25 μg mL-1) for in vitro parasite testing and 50, 25 and 12.5 μg mL-1 concentrations for in vitro cytotoxicity assays.
Parasites, media and in vitro antiplasmodial tests: The Plasmodium
falciparum strain used for the in vitro tests was W2,
a multi-resistant isolate from Vietnam. The isolate was maintained in continuous
culture in the parasitology lab of the pharmacy faculty of the Universite de
la Mediterranee, Marseille, France. In 75 cm2 flasks, the parasite
strains were maintained in continuous culture using 20 mL of RPMI 1640 medium
supplemented with 10% human serum, 25 mM N-2-hydroxyethylpiperazine-N-2-ethanesulfonic
acid (HEPES, Gibco-BRL, Paisley, Scotland) and 25 mM NaHCO3 as previously described
by Trager and Jensen (1976). Washed human group A+ erythrocytes
served as host cells and the cultures were incubated at 37°C in an atmosphere
of 6% CO2, 10% O2 and 84% N2 with 90% humidity.
Parasitemia was monitored daily and maintained between 1 and 6%. Dilutions,
when performed, were done using non-infected A+ erythrocytes stored at hematocrit
50%. Medium renewal and microscopic observation of prepared blood smears fixed
with methanol and stained with 10% Giemsa stain were performed daily.
Parasitized blood at a hematocrit of 2% with parasitemia between 1.5 and 2% was suspended in 500 μL culture medium with different concentrations of fractions. A growth control (parasitized blood only), positive controls with chloroquine (the reference drug) at different concentrations (2.5, 1, 0.5 and 0.1 μM) and negative controls with sterile DMSO (0.2, 0.1, 0.05 and 0.025%) were prepared under the same conditions and were used in each series of tests. Nonparasitized blood was used to adjust the flow cytometer (Facsort Becton Dickinson France Paris). Each concentration of extract and control was tested in duplicate in 96 well polystyrene plates (Nunc Brand products, Fisher, Paris, France). Incubation was performed in a CO2 atmosphere at 37°C during 48 h without medium renewal. After incubation, plates were centrifuged and the supernatants replaced (cells remained in the bottoms of the wells) with 180 μL hydroethidine solution (0.05 mg mL-1 in PBS). After 25 min of incubation in the dark at 37°C and three washes with PBS solution, red cells were suspended in 200 μL of PBS. A final dilution of 10 μL of suspended red cells in 1 mL of PBS was used for determination of the number of parasitized cells by flow cytometry (Beckton Dickinson Facsort). The IC50-Plasmodium was defined as the concentration of an extract that produced 50% inhibition of parasite growth in comparison with a control culture with DMSO. The IC50-Plasmodium was determined from dose-response.
Cell lines, media and cytotoxicity tests: K562S cells, which derived
from human chronic myeloid leukemia, were maintained in continuous culture in
RPMI 1640 medium (Eurobio, Paris, France) supplemented with 10% fetal bovine
serum (Eurobio, Paris, France), 25 mM HEPES, 25 mM NaHCO3 and a 1%
mix of 200 mM l-glutamine, 10,000 IU mL-1 penicillin and 10 mg mL-1
streptomycin (Sigma). The tests were performed in 1 mL of medium containing
1.5x105 cells mL-1 in contact with each fraction at different concentrations
(50, 25 and 12.5 μg mL-1). A growth control (cells and medium
only), positive controls with doxorubicin at different concentrations (4.300,
0.430, 0.086, 0.040 and 0.215 μM) and a negative control with sterile DMSO
at a final concentration of 0.5% were made for each series of tests. Experiments
(concentrations of fractions) and controls were tested in duplicate in 24 well
polystyrene plates. Incubation was performed in a CO2 atmosphere
at 37°C for 72 h without medium change. Then, incorporation of Propidium
iodide into the nucleic acids of dead or dying cells, read by flow cytometer,
was used to determine the IC50-K562S (inhibiting concentration of
50% of the growing K562S cells compared to control culture) for each fraction.
A Selectivity Index (SI), corresponding to the ratio between cytotoxic and
antiparasitic activities, was evaluated for each tested extract according to
the following formula:
SIPlasmodium = IC50 K562S/IC50
Data analysis: Data were entered and analyzed using Microsoft Excel
2007. Parasites viability for all concentrations tested was calculated by subtracting
the control value (value obtained with negative control). A concentration-response
curve (percentage of parasitemia or percentage of cells proliferation versus
log concentration) was plotted for each fraction and 50% inhibitory concentration
IC50 was calculated compared to control by using table curve 5.0
Crude alkaloid extract and semi purified fractions: The first fraction obtained from Zanthoxylum zanthoxyloides bark of trunk was made with 40 g of powdered bark of trunk giving 668 mg of crude alkaloid. The visualization of the separated bands on PPTLC at 254 and 366 nm wavelength UV light revealed the presence of 15 bands representing semi purified alkaloids fractions. The polarity of fractions for this system of solvents decreased with the increases of fractions number. Fraction 1 (117.7 mg) is the more polar and fraction 15 the less polar. Based on the results of the thin layer chromatogram of each fraction, we pooled fractions 11, 12, 13, 14, 15 because of similarities of profile and a total of 11 fractions were submitted to biological evaluation. The weight of these semi purified fractions was summarized in Table 1. The revelation test using Dragendorffs reagent showed the presence of alkaloid in all semi purified fractions with high intensity of coloration in fractions 1, 2, 3, 4, 9 and 11. Fractions 5, 6, 7, 8 and 10 did not react with Dragendorffs reagent.
||Weight of fractions obtained from crude alkaloid extract of
||In vitro antiplasmodial activity of semi purified fractions
from Z. zantoxyloïdes bark of trunk against W2 strains of Plasmodium
falciparum, antiproliferative activity on K562S cells and selectivity
In vitro antiplasmodial and antiproliferative effects: The IC50 of chloroquine, the reference drug, was 700 nM for multiresistant W2 strains of Plasmodium falciparum. The in vitro antiplasmodial activity of these semi purified fractions is summarized in Table 2. A total of six semi purified fractions collected from the crude alkaloid extract of bark of trunk of Z. zanthoxyloïdes (fraction 1, 2, 3, 4, 9 and 11) displayed good activity with IC50 less than 10 μg mL-1 and high activity for fractions 2, 3 and 4 which displayed IC50 less than 5 μg mL-1.
Antiproliferative activity against K562S cells was evaluated for all semi purified fractions. The IC50 of doxorubicine, the reference drug for the test, was 0.02 μM. Results of antiplasmodial and toxicity assays of these semi purified fractions are summarized in Table 2. The toxicity of each semi purified fraction was established by analysis of the SI.
Zanthoxylum zanthoxyloides is very well known specie, widely used in
the African pharmacopoiea, frequently mentioned and that crude extracts from
roots have already been evaluated in vitro against Plasmodium strains
(Kassim et al., 2005). In this study we focussed
our research on bark of trunk of this plant instead to roots for ecological
reason and sustainability of plants and the antiplasmodial and cytotoxicity
activities, respectively against W2 strains and K562 cells of semi-purified
fractions obtained by Preparative chromatography were investigated because of
good activity and selectivity index of crude alkaloid extract (Gansane
et al., 2009a, b). To our knowledge his is
the first time that semi purified fractions from extract from bark of trunk
for Z. zanthoxyloïdes is tested for antiplasmodial activity against
resistant strains of P. falciparum. According to Deharo
et al. (2001), from a total of 11 semi purified fractions collected,
six (fraction 1, 2, 3, 4, 9 and 11) displayed good activity with IC50
less than 10 μg mL-1 and high activity for fractions 2, 3 and
4 which displayed IC50 less than 5 μg mL-1 suggesting
that the antiplasmodial compounds present an semi polar nature with the system
of solvent used for fractionation. These 6 fractions intensely reacted with
Draggendorfs reagent confirming the presence of alkaloids like quinine,
which is an antimalaria compound isolated from genus Cinchona and formulated
to antimalaria drug currently used to treat severe malaria. However no fraction
displayed better antiplasmodial activity than the crude alkaloid extract fraction
with IC50 = 1.16 μg mL-1 obtained in previous study
(Gansane et al., 2009a, b)
although this IC50 obtained with the crude alkaloid extract was close
to that obtained with fraction 3 (IC50 = 1.91 μg mL-1).
It was so evident that the overall antiplasmodial activity of the crude extract
was due to the synergistic effects of these fractions with maybe a great contribution
of fraction 3. Purification of these fractions 2, 3, 4 and 9 upon fractionation
could allow isolation of pure alkaloid compound with very good activity against
malaria parasites. Many pure compounds such as 3,4-O-divanilloylquinic acid,
3,5-O-divanilloylquinic acid, 4,5-O-divanilloylquinic acid and the pure alkaloid
fagaronine were isolated from roots of Z. zanthoxyloides by previous
studies (Ouattara et al., 2004; Messmer
et al., 1972). Fagaronine which is a benzophenanthridine alkaloid
was tested against sensitive strain of Plasmodium falciparum and displayed
IC50 = 0.018 μg mL-1 (Kassim
et al., 2005) and the three new isomeric divanilloylquinic acids
were tested for their antisickling activity (Ouattara et
al., 2004, 2009) and never for the antiplasmodial
activity. There is so a need to know if Fagaronine or others pure compound are
presents in the bark of trunc of Z. zantoxyloïdes.
To determine the specificity of the antiplasmodial activity of these semi-purified
fractions, we tested them for cytotoxicity against K562S cells. The corresponding
IC50 and selectivity index of fractions 2, 3, 4 and 9 suggest that
the observed good antiplasmodial activity might not be due to the toxicity activity
of these fractions. Fagaronine displayed an IC50 = 2.22 μg mL-1
against K562S cells in previous study (Prado et al.,
2004) seems to be more cytotoxic than our semi purified fractions 2, 3,
4 and 9.
These results justify the use of bark of trunk from Z. zanthoxyloides
for the treatment of malaria/fever in the province of Comoe and allow us further
investigation to purify, isolate molecules and to determine mechanism of action
and DMPK profile of leads compounds from semi purified fractions 2, 3, 4 and
9. This is the first time that semi purified fractions from extract from bark
of trunk for Z. zanthoxyloïdes is tested for antiplasmodial activity
against resistant strains of P. falciparum.
This study was supported by UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training (TDR) Project ID No: A30930. We thank the Faculty of Pharmacy, University of the Mediterranee, France for their support. Dr Adama GANSANE is a PhD fellow supported by UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training (TDR) Project ID No: 30838.
Deharo, E., G. Bourdy, C. Quenevo, V. Munoz, G. Ruiz and M. Sauvain., 2001.
A search for natural bioactive compounds in Bolivia through a multidisciplinary approach. Part V. Evaluation of the antimalarial activity of plants used by the Tacana Indians. J. Ethnopharmacol., 77: 91-98.CrossRef | PubMed |
Gansane, A., S. Sanon, L.P. Ouattara, A. Traore and S. Hutter et al
Antiplasmodial activity and toxicity of crude extracts from alternatives parts of plants widely used for the treatment of malaria in Burkina Faso: Contribution for their preservation. Parasitol. Res., 106: 335-340.CrossRef | PubMed | Direct Link |
Gansane, A., I. Nebie, I. Soulama, A. Tiono and A. Diarra et al
Change of antimalarial first line treatment in burkina faso in 2005. Bull. Soc. Pathol. Exot., 102: 31-35.PubMed | Direct Link |
Kassim, O.O., M. Loyevsky, B. Elliott, A. Geall, H. Amonoo and V.R. Gordeuk, 2005.
Effects of root extracts of Fagara zanthoxyloides
on the in vitro
growth and stage distribution of Plasmodium falciparum
. Antimicrob. Agents Chemother., 49: 264-268.CrossRef | PubMed | Direct Link |
Messmer, W.M., M. Tin-Wa, H.H. Fong, C. Bevelle, N.R. Farnsworth, D.J. Abraham and J. Trojanek, 1972.
Fagaronine, a new tumor inhibitor isolated from Fagara zanthoxyloides
Lam. (Rutaceae). J. Pharm. Sci., 61: 1858-1859.PubMed | Direct Link |
Ouattara, B., O. Jansen, L. Angenot, I.P. Guissou, M. Frederich, P. Fondu and M. Tits, 2009.
Antisickling properties of divanilloylquinic acids isolated from Fagara zanthoxyloides
Lam. (Rutaceae). Phytomedicine, 16: 125-129.CrossRef |
Ouattara, B., L. Angenot, P. Guissou, P. Fondu and J. Dubois et al
LC/MS/NMR analysis of isomeric divanilloylquinic acids from the root bark of Fagara zanthoxyloides
Lam. Phytochemistry, 65: 1145-1151.CrossRef | PubMed | Direct Link |
Prado, S., S. Michel, F. Tillequin, M. Koch and B. Pfeiffer et al
Synthesis and cytotoxic activity of benzo[c][1,7] and [1,8]phenanthrolines analogues of nitidine and fagaronine. Bioorg. Med. Chem., 12: 3943-3953.CrossRef | PubMed | Direct Link |
Rogier, C. and J.F. Trape, 1999.
Malaria: Organizations, network and new initiatives. Med. Trop., 59: 55-56.PubMed | Direct Link |
Rowe, A.K., S.Y. Rowe, R.W. Snow, E.L. Korenromp and J.R. Schellenberg et al
The burden of malaria mortality among African children in the year 2000. Int. J. Epidemiol., 35: 691-704.CrossRef | PubMed | Direct Link |
Snow, R.W., M. Craig, U. Deichmann and K. Marsh, 1999.
Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull. World Health Organ., 77: 624-640.PubMed | Direct Link |
Trager, W. and J.B. Jensen, 1976.
Human malaria parasites in continuous culture. Sciences, 193: 673-675.CrossRef | PubMed | Direct Link |
Traore, A., A.I. Derme, S. Sanon, A. Gansane, Y. Ouattara, I. Nebie and S.B. Sirima, 2009.
Connaissances ethnobotaniques et pratiques phytotherapeutiques des tradipraticiens de sante de la Comoe pour le traitement du paludisme: Processus d'une recherche scientifique de nouveaux antipaludiques au Burkina Faso. Ethnopharmacologia, 43: 35-46.